Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
34,234,622
-
Share change
-
+1,597,106
-
Total reported value
-
$505,296,990
-
Put/Call ratio
-
95%
-
Price per share
-
$14.76
-
Number of holders
-
98
-
Value change
-
+$23,535,263
-
Number of buys
-
43
-
Number of sells
-
47
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2020
As of 30 Sep 2020 Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,234,622 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, BOXER CAPITAL, LLC, BlackRock Inc., Avidity Partners Management LP, MPM ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, and FRAZIER MANAGEMENT LLC.
This table shows 98 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.